Organised By
Kenes Group, Office: Kenes M+
|
Keynote / Plenary |
Conference Presentations |
Issue Panels |
Poster Sessions |
|
Start Time |
End Time |
Event |
||
|
09:00 |
10:30 |
Assessment and Use of Patient-reported Outcome Data for SDM in Medicine with a Special Focus on Oncology Course Director: Bernhard Holzner, Department of Psychiatry II, Health Outcomes Research Unit, Austria |
||
|
10:30 |
11:00 |
Tea and Coffee Break |
||
|
11:00 |
12:30 |
Assessment and Use of Patient-reported Outcome Data for SDM in Medicine with a Special Focus on Oncology (continued) |
||
|
12:30 |
14:00 |
Lunch break (on your own) |
||
|
14:00 |
15:30 |
Causal Diagrams, Target Trial Emulation and Causal Inference in Medical Decision Making – Theory and Application in Real World Observational Data and Pragmatic Trials Course Director: Uwe Siebert, UMIT TIROL – University for Health Sciences and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Austria Additional Faculty: |
||
|
15:30 |
16:00 |
Tea and Coffee Break |
||
| 16:00 | 17:30 | SMDM Core Course: Causal Diagrams, Target Trial Emulation and Causal Inference in Medical Decision Making – Theory and Application in Real World Observational Data and Pragmatic Trials (continued) | ||
| 17:30 | 19:00 | Poster Session 1 & Welcome Reception | ||
|
Start Time |
End Time |
Event |
||
|
09:00 |
10:30 |
SMDM Core Course: Introduction to Shared Decision Making and Patient Decision Aids Course Director: Marieke de Vries, Radboud University, Institute for Computing and Information Sciences, The Netherlands |
||
|
10:30 |
11:00 |
Tea and Coffee Break |
||
|
11:00 |
12:30 |
SMDM Core Course: Introduction to Shared Decision Making and Patient Decision Aids (continued) |
||
|
12:30 |
14:00 |
Lunch break (on your own) |
||
|
14:00 |
15:30 |
SMDM Core Course: Introduction to the Psychology of Medical Decision Making Course Director: Olga Kostopoulou, Imperial College London, UK Additional Faculty: Martine Nurek, Imperial College London, UK |
||
|
15:30 |
16:00 |
Tea and Coffee Break |
||
| 16:00 | 17:30 | SMDM Core Course: Introduction to the Psychology of Medical Decision Making (continued) | ||
| 17:30 | 19:00 | Poster Session 1 & Welcome Reception | ||
|
Start Time |
End Time |
Event |
||
|
09:00 |
10:30 |
An Introduction to Research Prioritization and Study Design Using Value of Information Analysis Course Director: Jeremy D. Goldhaber-Fiebert, Stanford University School of Medicine, Stanford, Department of Health Policy, USA Additional Faculty: |
||
|
10:30 |
11:00 |
Tea and Coffee Break |
||
|
11:00 |
12:30 |
An Introduction to Research Prioritization and Study Design Using Value of Information Analysis (continued) |
||
|
12:30 |
14:00 |
Lunch break (on your own) |
||
|
14:00 |
15:30 |
Advanced Computation of Value of Information Measure to Determine Optimal Research Design Course Director: Anna Heath, The Hospital for Sick Children & University of Toronto, Child Health Evaluative Sciences, Canada |
||
|
15:30 |
16:00 |
Tea and Coffee Break |
||
| 16:00 | 17:30 |
Advanced Computation of Value of Information Measure to Determine Optimal Research Design (continued) |
||
| 17:30 | 19:00 | Poster Session 1 & Welcome Reception | ||
|
Start Time |
End Time |
Event |
||
|
09:00 |
10:30 |
An Introduction to Structural Equation Modeling for Medical Decision Making Research Course Director: Kristen Berg, CWRU and MetroHealth, Department of Medicine, USA Additional Faculty: |
||
|
10:30 |
11:00 |
Tea and Coffee Break |
||
|
11:00 |
12:30 |
An Introduction to Structural Equation Modeling for Medical Decision Making Research (continued) |
||
|
12:30 |
14:00 |
Lunch break (on your own) |
||
|
14:00 |
15:30 |
SMDM Core Course: Introduction to Medical Decision Analysis and Cost-Effectiveness Analysis Faculty: Beate Jahn, UMIT TIROL – University for Health Sciences and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Austria |
||
|
15:30 |
16:00 |
Tea and Coffee Break |
||
| 16:00 | 17:30 |
SMDM Core Course: Introduction to Medical Decision Analysis and Cost-Effectiveness Analysis (continued) |
||
| 17:30 | 19:00 | Poster Session 1 & Welcome Reception | ||
|
Start Time |
End Time |
Event |
||
|
09:00 |
10:30 |
What They Didn’t Teach You About Decision Modeling Course Director: John Graves, Vanderbilt University School of Medicine, Department of Health Policy, USA Additional Faculty: |
||
|
10:30 |
11:00 |
Tea and Coffee Break |
||
|
11:00 |
12:30 |
What They Didn’t Teach You About Decision Modeling |
||
|
12:30 |
14:00 |
Lunch break (on your own) |
||
|
14:00 |
15:30 |
What They Didn’t Teach You About Decision Modeling |
||
|
15:30 |
16:00 |
Tea and Coffee Break |
||
| 16:00 | 17:30 | What They Didn’t Teach You About Decision Modeling (continued) |
||
| 17:30 | 19:00 | Poster Session 1 & Welcome Reception | ||
|
Start Time |
End Time |
Event |
|
|
08:30 |
08:45 |
Welcome Remarks |
|
|
08:45 |
09:45 |
Keynote Lecture When Emotion Trumps Evidence: Challenges for the Public Understanding of Risk |
|
|
09:45 |
10:45 |
Top Rated Oral Abstract Presentations Chairs: Tobias Kurth (Berlin School of Public Health, Germany), Stijntje W. Dijk (Erasmus Medical Center, Netherlands) • Potential Global Loss of Life Expected Due to Covid-19 Disruptions to Organised Colorectal Cancer Screening, Francine Van Wifferen, Amsterdam UMC, Netherlands, OP-01 • Cost-effectiveness of Primary Human Papillomavirus (HPV) Triage Approaches Among Vaccinated Women in Norway: A Model-based Analysis, Allison Portnoy, Harvard T.H. Chan School of Public Health, USA, OP-02 • Incorporating Marginalized Populations into HPV Vaccine Modeling: A Systematic Review, Jennifer C. Spencer, The University of Texas at Austin, USA, OP-03 • Sociometric Proof of Concept of a 7 Step Health Achievement Measurement Approach for Neighborhoods, Adam T. Perzynski, The Metrohealth System, USA, OP-04 |
|
|
10:45 |
11:15 |
Tea and Coffee Break |
|
|
11:15 |
12:30 |
Oral Presentations 1B Chairs: Jef Van den Ende (University of Antwerp, Belgium), Felicitas Kühne (Pfizer, Germany) • Risk Stratification in the Context of Cancer Screening: Implications of Constraints on Strata-specific Screening Policies for Efficiency and Equity, James F. O. Mahony, Trinity College Dublin, Ireland, OP-05 • Cost-effectiveness Analysis of Population-based Screening for Chronic Obstructive Pulmonary Disease in China, Yiwen Fan, Heidelberg University, Germany, OP-06 • A Multisite Randomized Trial of a Veteran-centric Lung Cancer Screening Decision Aid, Marilyn M. Schapira, University of Pennsylvania, USA, OP-07 • Long-term Benefits and Harms of Early Colorectal Cancer Screening in German Individuals with Familial Cancer Risk - A Decision Analysis Within Farkor, Gaby Sroczynski, UMIT TIROL, Austria, OP-08 • Modeling Optimal Stop Ages for Colorectal Cancer Screening Based on Sex, Comorbidity and Screening History, Matthias Harlass, Erasmus MC, Netherlands, OP-09 |
|
|
12:30 |
13:45 |
Poster Session 2 & Lunch |
|
|
13:45 |
15:00 |
Oral Presentations 2E Chairs: Beate Sander (University of Toronto, Canada), Eddymurphy U. Akwiwu (Amsterdam UMC, Netherlands) • Comparing Historical Surveillance Data of Two-strain Influenza Years with Agent-based Modeling to Investigate the Existence of Viral Interference, Alexis Mandell, University of Pittsburgh, USA, OP-15 • The Facilitators and Barriers to Reducing Falls Among Community-dwelling Older Adults from Clinicians’ Perspective: A Systems Modelling Approach, Vanessa Jean Wen Koh, Duke Nus Medical School, Singapore, OP-16 • An Efficient Nonparametric Sampling Method of Time to Event for Individual-level Models, David Ulises Garibay Treviño, Health Research Consortium (CISIDAT), Mexico, OP-17 • Developing an Agent-based Model to Track Hepatitis C Elimination in an Ongoing Pandemic Era, William Wl Wong, University of Waterloo, Canada, OP-18 • Non-parametric survival estimation of a progressive, multi-state Markov model with interval-censored event times, Zachary Waller, Queen's University Belfast, UK, OP-19 |
|
|
15:00 |
15:30 |
Tea and Coffee Break |
|
|
15:30 |
16:45 |
Oral Presentations 3I Chairs: Anna Heath (University of Toronto/The Hospital for Sick Children, Canada), Dan Greenberg (Ben-Gurion University of the Negev, Israel) • The Effects of a Short Educational Intervention on Opinions Regarding Treatments for Opioid Use Disorder, Colin Macleod, University of Michigan, USA, OP-25 • Developing a Patient Decision Aid for People with Relapsing Remitting Multiple Sclerosis Making Disease Modifying Treatment Decisions, Hilary Louise Bekker, University of Leeds, UK, OP-26 • Cost-effectiveness Analysis of the Disease Management Program Herzmobil Tirol Along the Cohort Study, Beate Jahn, UMIT TIROL, Austria, OP-27 • Pilot Testing a Web-Based Decision Aid in Breast Cancer for Personalised Treatment Choices: A Case Analysis, Natalia Oprea, SDA Bocconi School of Management, Italy, OP-28 • The Short and Longer-term Impact of a Cognitive-behavioral and Mindfulness Intervention on Crohn's Disease (CD) Patients’ Utility-weights, Ruslan Sergienko, Ben Gurion University of the Negev, Israel, OP-29 |
|
|
16:45 |
17:00 |
Break to Move to Main Room |
|
|
17:00 |
18:00 |
Plenary Symposium 1 Chair: Jesse Jansen (Maastricht University, Netherlands) Panelists: |
|
|
19:30 |
23:00 |
Social Event at Reinhard Bär Restaurant |
|
Start Time |
End Time |
Event |
|
|
10:45 |
11:15 |
Tea and Coffee Break |
|
|
11:15 |
12:30 |
Oral Presentations 1A Chairs: Helmut Sitter (Philipps University of Marburg, Germany), Sibylle Puntscher (UMIT TIROL, Austria) • Graphically Represented Medical Information Is Harder to Process and Is Rather Chosen Than Numerically Represented Information, Kevin Tiede, Max Planck Institute For Human Development, Germany, OP-10 • Do Physicians Interpret Cumulative Risk Curves Accurately? Wolfgang Gaissmaier, University of Konstanz, Germany, OP-11 • The Making Numbers Meaningful Systematic Review of Communicating Health Numbers: Evidence for Communicating Probabilities to Achieve Point-level Tasks, Brian J. Zikmund Fisher, University of Michigan, USA, OP-12 • Effective Sample Size: a Promising Tool to Communicate Uncertainty in Individual Predictions? Ewout W. Steyerberg, Leiden University Medical Center, Netherlands, OP-13 • Cure Vs. Toxicity: Quantifying Preferences for Non-surgical Management of Rectal Cancer Using a Discrete Choice Experiment, Edward JD Webb, University of Leeds, UK, OP-14 |
|
|
12:30 |
13:45 |
Poster Session 2 & Lunch |
|
|
13:45 |
15:00 |
Oral Presentations 2F Chairs: Olga Kostopoulou (Imperial College London, UK), Praveen Thokala (The University of Sheffield, UK) • Quality of Life of Critically Ill Adult Cancer Patients Before and After Icu Admission, Al Rabayah Abeer Ahmad Hamdan, King Hussein Cancer Center, Jordan, OP-20 • Universalism Over Power: A Systematic Integrative Review of Shared Decision-making Models Through the Lens of Schwartz’s Value Theory, Anne Stiggelbout, Leiden University Medical Center, Netherlands, OP-21 • Evaluation of Long-term Benefits and Harms of Extended Age Limits of Mammography in Germany – A Decision Analysis for an Iqwig Benefit Assessment, Gaby Sroczynski, UMIT TIROL, Austria, OP-22 • Decision Making and Intrafamilial Trade-offs in Response to Asthma Care Costs: a Qualitative Study, Alison A. Galbraith, Harvard Medical School And Harvard Pilgrim Health Care Institute, USA, OP-23 |
|
|
15:00 |
15:30 |
Tea and Coffee Break |
|
|
15:30 |
16:45 |
Oral Presentations 3J Chairs: Gaby Sroczynski (UMIT TIROL, Austria), Zachary Waller (Queen's University Belfast, UK) • Can Cost-effectiveness Acceptability Curves Mask Differences in Subgroups? Shannon Hearney, University of California Davis, USA, OP-30 • Expected Value of Sample Information of Multi-arm Multi-stage Trial Designs Comparing Directly Acting Oral Anticoagulants in Atrial Fibrillation, Mary Ward, University of Bristol, UK, OP-31 • Extrapolating Discrete-time Disease Evolution Data in Limited Series of Transition Probability Matrices: A Continuous-time Markov Chain Approach, Murat Kurt, Bristol Myers Squibb, USA, OP-32 • Using a Pedagogical Model of the Cost-effectiveness of Cancer Screening to Understand Convexity of the Efficient Frontier, Yi Shu Lin, Trinity College Dublin, Ireland, OP-33 • Use Of Real-world Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis, Janharpreet Singh, University of Leicester, UK, OP-34 |
|
|
16:45 |
17:00 |
Break to Move to Main Room |
|
Start Time |
End Time |
Event |
|
|
10:45 |
11:15 |
Tea and Coffee Break |
|
|
11:15 |
12:30 |
Issue Panel 1C Chair: Talitha Feenstra (National Institute for Public Health and the Environment (RIVM), Netherlands) Panelists: |
|
|
12:30 |
13:45 |
Poster Session 2 & Lunch |
|
|
13:45 |
15:00 |
Issue Panel 2G Chair: Alexander Kuhlmann (University of Halle, Germany) Panelists: |
|
|
15:00 |
15:30 |
Tea and Coffee Break |
|
|
15:30 |
16:45 |
Issue Panel 3L Chair: Philip Clarke (University of Oxford, UK) Panelists: |
|
|
16:45 |
17:00 |
Break to Move to Main Room |
|
Start Time |
End Time |
Event |
|
|
10:45 |
11:15 |
Tea and Coffee Break |
|
|
11:15 |
12:30 |
Issue Panel 1D Chairs: Sarah Friedrich (University of Augsburg, Germany) Panelists: |
|
|
12:30 |
13:45 |
Poster Session 2 & Lunch |
|
|
13:45 |
15:00 |
Issue Panel 2H Chairs: Hilary Louise Bekker (University of Leeds, UK), Danielle Timmermans (Amsterdam UMC, Netherlands) Panelists: Hilary Louise Bekker, University of Leeds, UK |
|
|
15:00 |
15:30 |
Tea and Coffee Break |
|
|
15:30 |
16:45 |
|
|
|
16:45 |
17:00 |
Break to Move to Main Room |
|
Start Time |
End Time |
Event |
|
|
07:30 |
09:00 |
Poster Session 3 & Tea/Coffee |
|
|
09:00 |
10:00 |
Top Rated Oral Abstract Presentations Chairs: Danielle Timmermans (Netherlands), Negin Hajizadeh (Bayer AG, Spain) • Vignette-based experiment comparing UK General Practitioners’ risk assessments and antibiotic prescribing decisions to a clinical prediction rule, Martine Nurek, Imperial College London, UK, OP-35 • Comparative effectiveness of 3 interventions on patient engagement and shared decision making: Results from a cluster randomized controlled trial, Ming Tai Seale, University of California San Diego, USA, OP-36 • Using Curiosity to Counter Health Information Avoidance, Yana Litovsky, University of Innsbruck, Austria, OP-37 • Development of a Decision Support Tool for Biologic Therapy Withdrawal Decisions in Non-systemic Juvenile Idiopathic Arthritis, Janine A. Van Til, University of Twente, Netherlands, OP-38 |
|
|
10:00 |
11:00 |
Plenary Symposium Chairs: Uwe Siebert (UMIT TIROL, Austria) Panelists: |
|
|
11:00 |
11:30 |
Tea and Coffee Break |
|
|
11:30 |
12:45 |
Oral Presentations 4M Chairs: Angie Fagerlin (University of Utah School of Medicine, USA), Ahmed Mohammed Patel (Imperial College of London, UK) • Evaluation of the Minimal Clinically Important Difference in HRQoL (PROQOL-HCV) after DAA treatment for chronic hepatitis C (ANRS CO22 HEPATHER), Abbas Mourad, Aix Marseille University, France, OP-39 • Women’s Interest, Knowledge, and Attitudes About Anti-Mullerian Hormone Testing: An Online Randomised Trial, Jesse Jansen, Maastricht University, Netherlands, OP-40 • Mapping Between the MANSA Quality of Life Instrument and EQ-5D-3L for Mental Health Problems, Sean P. Gavan, The University of Manchester, UK, OP-41 • Preferences of Citizens in Peru for School Opening during a Public Health Crisis: A Participatory Value Evaluation Study, Karen Trujillo Jara, Erasmus University, Netherlands, OP-42 • Strategies to Improve Health-related Quality of Life of Patients Receiving CAR T-Cell Therapy: A Simulation Analysis, Zeynep Hasgul, Harvard Medical School, USA, OP-43 |
|
|
12:45 |
14:00 |
Poster Session 4 & Lunch |
|
|
14:00 |
15:15 |
Oral Presentations 5Q Chairs: Joseph Pliskin (Ben-Gurion University of the Negev, Israel), Davene Wright (Harvard Medical School, USA) • Extending Beyond Aggregate Cost-Effectiveness Results in Diagnostics Evaluation: The Case of Software Fusion for the Diagnosis of Prostate Cancer, Ana Duarte, University of York, UK, OP-49 • Cost-Effectiveness Analysis of Non-Invasive Tests to Identify Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease, Lina Gruneau, Linköping University, Sweden, OP-50 • What Errors Impact Situation Awareness and Decision Making for Primary Care Clinicians? Ahmed Mohammed Patel, Imperial College London, UK, OP-51 • Differences in Information Seeking and Confidence Among Medical Students in Diagnostic Decisions, Sriraj Aiyer, University of Oxford, UK, OP-52 • Integrating Personalized Survival and Risk Scores in Decision Making About Left Ventricular Assist Device Therapy: Clinician and Patient Perspectives, Jennifer S. Blumenthal Barby, Baylor College of Medicine, USA, OP-53 |
|
|
15:15 |
15:45 |
Tea and Coffee Break |
|
|
15:45 |
16:45 |
Plenary Symposium 3 Chair: |
|
|
16:45 |
17:00 |
Awards and Closing Ceremony |
|
|
17:00 |
Adjournment |
|
Start Time |
End Time |
Event |
|
|
07:30 |
09:00 |
Poster Session 3 & Tea/Coffee |
|
|
11:00 |
11:30 |
Tea and Coffee Break |
|
|
11:30 |
12:45 |
Oral Presentations 4N Chairs: Emily Burger (University of Oslo, Norway), Eline Krijkamp (Erasmus University, Netherlands) • Spillovers in Health Economic Evaluation and Research (SHEER) Task Force: Recommendations for Best Practice and a Future Research Agenda, Edward Henry, J.E. Cairnes School Of Business & Economics, University Of Galway, Ireland, OP-44 • Health-Economic Evaluation of a Disease Management Program for Chronic Heart Failure in Austria – A Decision-Analytic Modeling Study, Beate Jahn, UMIT TIROL, Austria, OP-45 • Healthcare Cost-Effectiveness Evaluations: Comparing and Contrasting Methods for Pharmaceuticals, Medical Devices and Digital Health Technologies, Hayden Holmes, York Health Economics Consortium, UK, OP-46 • Which Shared Decisions can be Supported by Outcome Data? – Results From the Dutch Outcome-Based Healthcare Program, Domino Determann, National Health Care Institute, Netherlands, OP-47 • Extrapolation of Survival Data Using External Information in a Bayesian Framework - A Simplified Approach and an Application, David McConnell, St James's Hospital, Ireland, OP-48 |
|
|
12:45 |
14:00 |
Poster Session 4 & Lunch |
|
|
14:00 |
15:15 |
Oral Presentations 5R Chairs: Heather T. Gold (NYU Langone Health, USA), Al Rabayah Abeer Ahmad Hamdan (King Hussein Cancer Center, Jordan) • Model for ASsessing the Value of AI in medical ımaging (MAS-AI), Iben Fasterholdt, CIMT - Centre for Innovative Medical Technology, Odense University Hospital, Denmark, OP-54 • Optimizing Colorectal Cancer Surveillance Policies Considering Uncertainty in the Number and Size of Detected Adenomatous Polyps: A POMDP Approach, Amin Asadi, University of Twente, Netherlands, OP-55 • Patients’ Willingness to Accept Adverse Event and Cost Trade-Offs for Reduced Risk of Non-Melanoma Skin Cancer: a discrete-choice experiment, Marco Boeri, RTI Health Solutions, UK, OP-56 • Estimating Adenoma Incidence and Progression Rates in Individuals with a Family History of Colorectal Cancer Using a Bayesian Three-State Model, Eddymurphy U. Akwiwu, Amsterdam UMC, Netherlands, OP-57 |
|
|
15:15 |
15:45 |
Tea and Coffee Break |
|
Start Time |
End Time |
Event |
|
|
07:30 |
09:00 |
Poster Session 3 & Tea/Coffee |
|
|
11:00 |
11:30 |
Tea and Coffee Break |
|
|
11:30 |
12:45 |
Issue Panel 4P Chair: Bruce Schackman (Weill Cornell Medical College, USA) Panelists: |
|
|
12:45 |
14:00 |
Poster Session 4 & Lunch |
|
|
13:00 |
13:50 |
Building and Sustaining Strong Research Collaborations Moderator: Jenny Spencer (University of Texas at Austin, USA) Panelists: |
|
|
14:00 |
15:15 |
Issue Panel 5T Chair: Marta Soares (University of York, UK) Panelists: |
|
|
15:15 |
15:45 |
Tea and Coffee Break |
|
Start Time |
End Time |
Event |
|
|
07:30 |
09:00 |
Poster Session 3 & Tea/Coffee |
|
|
11:00 |
11:30 |
Tea and Coffee Break |
|
|
11:30 |
12:45 |
Issue Panel 4O Chair: Nachman Ash (Ministry of Health, Israel) Panelists: |
|
|
12:45 |
14:00 |
Poster Session 4 & Lunch |
|
|
14:00 |
15:15 |
Issue Panel 5S Chair: Anna Heath (University of Toronto/The Hospital for Sick Children, Canada) Panelists:
|
|
|
15:15 |
15:45 |
Tea and Coffee Break |
Session Date: 21 May 2023
Session Time: 17:30-18:30
| Poster Number | Title | Presenter |
| PP-001 | Cost-effectiveness of an In-development Adult-formulated Pneumococcal Vaccine in Older Us Adults | Kenneth J Smith, University of Pittsburgh School of Medicine, USA |
| PP-002 | A Comparison of International Modelling Methods to Evaluate Health Economics of Colorectal Cancer Screening: A Systematic Review | Olivia Adair, Queen's University Belfast, UK |
| PP-003 | Cost-effectiveness Analysis of Big-3 Screening Program: Lung Cancer, Chronic Obstructive Pulmonary Disease and Cardiovascular Disease | Carina M Behr, University of Twente, Netherlands |
| PP-004 | Does Socio-economic Status Affect the Cost-effectiveness of the Surgical Treatment of Pancreatic Cancer At High Vs. Low-volume Centers in California? | Shannon Hearney, University of California Davis, USA |
| PP-005 | Systematic Overview of Economic Evaluations On Nature-based Social Prescribing for Improvement of Physical and Mental Health | Sibylle Puntscher, UMIT TIROL, Austria |
| PP-006 | The Burden of Substandard and Falsified Pediatric Malaria Medicines Across Six African Countries | Colleen R. Higgins, UNC Eshelman School of Pharmacy, Germany |
| PP-007 | Cost-consequence Analysis of Demand Generation Strategies for Hiv Pre-exposure Prophylaxis (prep) Use in Vulnerable Population Aged 15 to 19 | Natacha Cerchiari, University of São Paulo, Brazil |
| PP-008 | Simulating the Cancer Immunotherapy Pathway Towards Optimization of a Test Panel for Managing Toxic Adverse Events | Frederik Anne Van Delft, University of Twente, Netherlands |
| PP-009 | Cost-utility Analysis of Trifluridine/ Tipiracil in Treating Metastatic Colorectal Cancer in Previously Treated Patients in Jordan | Abeer Al Rabayah, Department of Pharmacy, Jordan |
| PP-010 | ‘shared Steps and Checks’: a Didactic 6-step Model for Teaching Shared Decision Making in Severe Mental Health Care | Doris Verwijmeren, Tilburg University, Netherlands |
| PP-011 | The Making Numbers Meaningful Systematic Review of Communicating Health Numbers: Overview and Scoping Review Regarding Communicating Probabilities | Brian J Zikmund Fisher, University of Michigan, USA |
| PP-012 | Shared Decision Making with Patients with Limited Health Literacy: a Systematic Review of Risk Communication Strategies | Romy Richter, Care and Public Health Research Institute CAPHRI, Netherlands |
| PP-013 | The Support of Patient Decision Aids in Shared Decision Making. Communication of Options and Risk Communication | Romy Richter, Care and Public Health Research Institute CAPHRI, Netherlands |
| PP-014 | The Impact of Cultural and Religious Background On Acceptability and Utility of an Hpv Vaccination Decision Aid for Parents of Adolescents in Israel | Yulia Gendler, Ariel University, Israel |
| PP-015 | The Impact of a Multidisciplinary Team Based Training Approach On the Uptake of Shared Decision Making in Cardiac Surgery | Elias Hirsch, Halifax Infirmary, Canada |
| PP-016 | Charting Current Evidence On the Health and Non-health Benefits and Equity Impacts of Individual-level Economic Relief Programs During Epidemics | Beate Sander, University of Toronto, Canada |
| PP-017 | Novel Methodology in Network Meta-analysis of Time-to-event Data Using Blended Survival Curves | Zhaojing Che, University College London, UK |
| PP-018 | Impact of Wheelchair Dependency On Eq-5d Assessment in Patients with Friedreich’s Ataxia | Maresa Buchholz, German Center for Neurodegenerative Diseases e.V. (DZNE), Germany |
| PP-019 | Capitalizing On Spillover Effects Following Obesity-related Health Shocks: Opportunities for Practice and Policy | Davene R. Wright, Harvard Medical School and Harvard Pilgrim Health Care Institute, USA |
| PP-020 | Using Routinely Collected Data to Examine the Distributional Cost-effectiveness of Aaa Screening in England | Shainur Premji, University of York, UK |
| PP-021 | The Impact of Community-based Interventions to Prevent Obesity Among Children and Adults: An Updated Systematic Review | Julia Santamaria, UMIT TIROL, Austria |
| PP-022 | Systematic Review of Decision-analytic Modeling Studies in Loneliness and Nature-based Social Prescribing | Beate Jahn, UMIT TIROL, Austria |
| PP-023 | Development and International External Validation of a Model Predicting Iron Marker Recovery After Blood Donation | W Alton Russell, McGill University, Canada |
| PP-024 | Canadian Diabetes Microsimulation Model | Ian Sobotka, Sunnybrook Hospital, Canada |
| PP-025 | Impact of Discontinuation of Oral Anti-coagulation in Patients with Atrial Fibrillation Following a Major Bleeding Event | Ryan Mulholland, University of Glasgow, UK |
| PP-026 | Is It the Same to Invest in Health Care or Social Care? A Health Production Study Using Health and Social Expenditures | Tallys Kalynka Feldens, University of Porto, Portugal |
| PP-027 | “fully Vaccinated” and “up-do-date”: U.s. Public Understanding of Officially-used Covid-19 Vaccination Terms Varies by Vaccination Status | Aaron M Scherer, University of Iowa, USA |
| PP-028 | Prioritization of Surgical Patients During the Covid-19 Pandemic and Beyond: A Qualitative Exploration of Patients’ Perspectives | Anouk Van Alphen, Erasmus University Medical Center, Netherlands |
| PP-029 | Patients with Inflammatory Bowel Disease: Quality of Life, Disease Awareness, Preferences and Satisfaction Relationships | Sergey Golubev, Belarusian State Medical University, Belarus |
| PP-030 | The Difference in Technology Success Rates As a Threshold for Low Technology Adoption | Raf Van Gestel, Erasmus University Rotterdam, Netherlands |
| PP-031 | Projections of Anxiety Disorder Burden Beyond the Covid-19 Pandemic in Germany Using the Illness-death Model | Chisato Ito, Charité – Universitätsmedizin Berlin, Germany |
| PP-032 | A Simple Digital Tool to Facilitate Health Economic Models’ Validation: the Probabilistic Analysis Check Dashboard (pacboard) | Xavier G.L.V. Pouwels, University of Twente, Netherlands |
| PP-033 | An Iterative Method for Identifying Relevant Strategies for Simulation in Cost-effectiveness Analyses of Cancer Screening | Yi Shu Lin, Trinity College Dublin, Ireland |
| PP-034 | The Rules of the Game Matter: Determining Value-based Price-thresholds for Treatments with Multiple Indications | Jeremy D Goldhaber Fiebert, Stanford University, USA |
Session Date: 22 May 2023
Session Time: 13:15-13:45 and 15:00-15:30
| Poster Number | Title | Presenter |
| PP-035 | Why Colorectal Cancer Screening Programmes in Europe Are of Sub-optimal Intensity: A Systematic Review of Cost-effectiveness Analyses | Rajani Pokharel, Trinity College Dublin, Ireland |
| PP-036 | Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke | Chi Nguyen, Hanoi University of Pharmacy, Netherlands |
| PP-037 | Cost-effectiveness of Colorectal Cancer Screening in Individuals with Familial Cancer Risk in Germany – A Decision Analysis Within the Farkor Study | Gaby Sroczynski, UMIT TIROL, Austria |
| PP-038 | Willingness to Pay for Mrna-based Anti-cancer Treatment: Results From a Contingent Valuation in Israel | Omer Ben Aharon, Ben-Gurion University of the Negev, Israel |
| PP-039 | A Decision-analytic Framework and Model to Evaluate the and Cost Effectiveness of a Community-based Intervention to Prevent Obesity in Austria | Julia Santamaria, UMIT TIROL, Austria |
| PP-040 | Willingness to Pay for Health and Well-being by Applying a Societal Perspective in the Netherlands | Karen Trujillo Jara, Erasmus University, Netherlands |
| PP-041 | Cost-effectiveness of Ct in Patients with Atypical Chest Pain Clinically Referred for Invasive Coronary Angiography: Randomised Controlled Trial | Mahmoud Mohamed, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany |
| PP-042 | Detecting and Treating Pelvic Venous Incompetence in Women Experiencing Chronic Pelvic Pain: an Early Economic Model and Value of Information Analysis | Rob Hainsworth, The University of Manchester, UK |
| PP-043 | The Potential Contribution of Assertiveness to Interpersonal Professional Encounters and Decision-making Process: A Scoping Review | Maayan Gutgeld Dror, Tel Aviv University, Israel |
| PP-044 | Acceptability of a Shared Decision-making Intervention for Individuals Considering Pulmonary Rehabilitation Programme Options | Amy C Barradell, University of Leicester, UK |
| PP-045 | Supporting Preference Talk in Oncology with the Outcome Prioritization Tool: a Qualitative Implementation Study of a Conversation Tool | Romy Richter, Care and Public Health Research Institute CAPHRI, Netherlands |
| PP-046 | Highlighting Factors Contributing to Situation Awareness Errors in Primary Care | Ahmed Mohammed Patel, Imperial College London, UK |
| PP-047 | How Gps’ Risk Attitudes and Perceived Harms and Benefits Impact Their Cancer Referral Decisions | Bence Palfi, Imperial College London, UK |
| PP-048 | A Severely Fragmented Concept: a Q-methodological Investigation of Subjective Accounts of Severity in Priority Setting | Mille Sofie Stenmarck, Akerhus University Hospital, Norway |
| PP-049 | Early Health Technology Assessment of Novel Fracture Risk Screening Methods | Wei Xuan Lai, Duke-NUS Medical School, Singapore |
| PP-050 | Non-drug Interventions for Symptom Relief in Restless Legs Syndrome - Health Technology Assessment | Heidi Stürzlinger, Austrian Public Health Institute, Austria |
| PP-051 | Quality of Life Assessment Methodologies in Women with Brca-1/2 Mutation - a Systematic Review | Lára Rún Hallsson, UMIT TIROL, Austria |
| PP-052 | Effectiveness of Behavioural Economics-informed Interventions to Promote Physical Activity: a Systematic Review and Meta-analysis | Helena Reisgies, University of Cologne, Germany |
| PP-053 | Healthy Life-expectancy and Quality of Life of Patients with Cancer in Germany 2010 an 2019: Expansion of Morbidity but Less Reduced Burden of Disease | Ralph Brinks, Witten/Herdecke University, Germany |
| PP-054 | Need for Clarification of Requirements Regarding Regulatory and Reimbursement Criteria for Artificial Intelligence in Innovative Medical Products | Philipp Storz-Pfennig, GKV-Spitzenverband (National Association of Statutory Health Insurance Funds), Germany |
| PP-055 | Prediction Model and Protocols After Colectomy: Towards Home-based Monitoring for Complications | Annemieke Witteveen, University of Twente, Netherlands |
| PP-056 | The Impact of Midwifery Staffing Levels and Patient Demand On Mother and Baby Outcomes in Two Uk Local Maternity Delivery Wards | Richard Mattock, University of Leeds, United Kingdom |
| PP-057 | Modelling the Effect of Hba1c Monitoring On the Achievement of Targets Among Public Sector Diabetes Patients in South Africa | Elton Mukonda, University of Cape Town, South Africa |
| PP-058 | A Standardized Framework for Risk-based Assessment of Treatment Effect Heterogeneity in Observational Healthcare Databases | Alexandros Rekkas, Erasmus Medical Center,, Netherlands |
| PP-059 | Health and Economic Burden of Covid-19 Misinformation On Vaccine Hesitancy in Canada | Colleen R. Higgins, University of North Carolina at Chapel Hill, Germany |
| PP-060 | Taking the Shortcut: Simplifying Heuristics in Discrete Choice Experiments | Stella M Marceta, Erasmus University Medical Center, Netherlands |
| PP-061 | Impact of Violence On Provider Decision Making in Emergency Healthcare | Tracy Kuo Lin, Kalin Werner, PhD, USA |
| PP-062 | Finding Common Ground to Measuring Patient Involvement in Healthcare | Bente Skovsby Toft, Aarhus University Hospital, Denmark |
| PP-063 | Benefit-harm Analysis for Informed Decision Making On Participating in Colorectal Cancer Screening: a Modelling Study | Francine Van Wifferen, Amsterdam UMC, Netherlands |
| PP-064 | Did We Make the Right Decisions for Covid-19 Patients? A Cumulative Meta-analysis- and Value of Information-timeline Analysis of Monoclonal Antibodies | Stijntje W Dijk, Erasmus University Medical Center, Netherlands |
| PP-065 | Cancer-specific Health Utilities: Evaluation of the Clinical Validity and Measurement Properties of the Eortc Qlu-c10d in Various Cancer Populations | Micha Johannes Pilz, Medical University Innsbruck, Austria |
| PP-066 | A Hierarchical Bayesian Meta-analytic {helicobacter Pylori (h. Pylori)} Infection Generator for the Us Population | Jorge Roa, Hertie School of Governance, Germany |
Session Date: 23 May 2023
Session Time: 7:30-8:30
| Poster Number | Title | Presenter |
| PP-067 | Cost-effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (ckd-ap) | Praveen Thokala, University of Sheffield, UK |
| PP-068 | Targeted Naloxone Co-dispensing with Prescription Opioids: a Data-driven Cost-effectiveness Analysis | W Alton Russell, McGill University, Canada |
| PP-069 | Cost Utility Analysis of Indonesian Phytopharmaca for Type Ii Diabetes Mellitus Management: A Case Study of Inlacin | Didik Setiawan, Universitas Muhammadiyah Purwokerto, Indonesia |
| PP-070 | Cost-effectiveness Analysis of Increasing Access to Colorectal Cancer Diagnosis with Limited Colonoscopy Capacities: an Example From Thailand | Zeynep Hasgul, Harvard Medical School, USA |
| PP-071 | Cost-effectiveness of Magnetic Resonance Guided Laser Ablation Compared to Traditional Craniotomy for Treatment of Pediatric Drug-resistant Epilepsy | Taylor J Abel, University of Pittsburgh, USA |
| PP-072 | Overcoming the Limitations of the Cost-utility Framework Using a Cost-consequence Analysis | Robert Heggie, University of Glasgow, UK |
| PP-073 | Open Science Education – Training a New Generation of Health Economic Model Developers | Xavier Pouwels, University of Twente, Netherlands |
| PP-074 | Facilitators and Barriers of the Use of Prognostic Models for Clinical Decision Making in Acute Neurological Care: a Systematic Review | Ellen X. Y. Hu, Erasmus University Medical Center, Netherlands |
| PP-075 | Metromapping: Development of a Methodology to Redesign Care Paths to Support Shared Decision Making | Anne Stiggelbout, Leiden University Medical Center, Netherlands |
| PP-078 | Decision Making for Adolescents and Young Adults with Differences of Sex Development | Kristina Irene Suorsa Johnson, University of Utah Spencer Fox Eccles School of Medicine, USA |
| PP-079 | Validity and Responsiveness of the Eq-5d-3l in Friedreich’s Ataxia | Niklas Weber, German Center for Neurodegenerative Diseases e.V. (DZNE), Germany |
| PP-080 | Predicting the Impact of Covid-19 Mitigation Strategies in Pennsylvania, Usa | Mark S Roberts, University of Pittsburgh, USA |
| PP-081 | A Scenario-drafting Study To Explore Potential Future Implementation Pathways Of Ctdna Testing In Oncology | Astrid Kramer, Amsterdam UMC, Netherlands |
| PP-082 | Healthcare Costs and Outcomes Associated with Laboratory-confirmed Lyme Disease in Ontario, Canada: A Population-based Cohort Study | Beate Sander, University of Toronto, Canada |
| PP-083 | Health Technology Assessment Developments in India and Ways for Capacity Building | Nachiket Gudi, Manipal Academy of Higher Education (MAHE), India |
| PP-084 | Modeling Decarceration to Avert Infections and Cases of Covid-19 in U.s. Immigration Detention Facilities Prior to Vaccine Availability | Jeremy D Goldhaber Fiebert, Stanford University, USA |
| PP-085 | Targeting Late Effects After Breast Cancer for Ambulatory Monitoring: a Review | Annemieke Witteveen, University of Twente, Netherlands |
| PP-087 | Systematic Review and Network Meta-analysis On the Efficacy and Safety of Oral Ivermectin Vs Topical Permethrin in the Treatment of Scabies | Rowena F Genuino, University of the Philippines-Manila, Philippines |
| PP-088 | Efficacy and Safety of Sausalin in the Treatment of Patients with Opisthorchiasis | Gulnara Tuleshova, National Research Center of Health Development, Kazakhstan |
| PP-089 | Implementing a Digital Healthy Setting Approach: Results of a Swot Analysis for Development and Implementation of a Digital Health Promotion Platform | Mariella Seel, University for Continuing Education Krems, Austria |
| PP-090 | Estimating Inequality Aversion in Health in a Representative Sample of the Norwegian Population | Sindre August Horn, Bergen Centre for Ethics and Priority Setting (BCEPS), Norway |
| PP-091 | Quality of Life of Critically Ill Adult Cancer Patients Before and After Icu Admission | Abeer Al Rabayah, King Hussein Cancer Center, Jordan |
| PP-092 | Estimating Eq-5d-3l Utility Values From Eq-5d-5l for People with Mental Health Problems: A Comparison of Methods | Sean P Gavan, The University of Manchester, UK |
| PP-093 | Use of a Nonparametric Bayesian Method to Model Health State Preferences: An Application to Lebanese Sf-6d Valuations | Samer A Kharroubi, American University of Beirut, Lebanon |
| PP-094 | Sensitivity of Counterfactual Calculations Using Interrupted Time Series Analyses: An Analysis of Dispensations for Opioid Use Disorders in Ontario | Ahmed M Bayoumi, University of Toronto, Canada |
| PP-095 | Identifying Equity Constrained Subgroups Using Machine Learning, Decision Modelling and Optimal Policy Algorithms | David Glynn, University of York, UK |
| PP-096 | Not Another Correlation Coefficient: A Method to Adjust Cost-effectiveness Acceptability Curves in Economic Evaluations | Ali Jalali, Weill Cornell Medical College, USA |
| PP-097 | Extrapolating Discrete-time Disease Evolution Data in Limited Series of Transition Probability Matrices: A Continuous-time Markov Chain Approach | Murat Kurt, Bristol Myers Squibb, USA |
| PP-098 | Moving Beyond Qalys: A Composite Indicator to Measure the Benefit of Hearing Implants | Michael Urban, MED-EL Medical Electronics, Austria |
| PP-099 | A Modeling Framework for Public Health Decision Making During Pandemics - Reflections of the Optimagent Consortium | Wolfgang Bock, RPTU Kaiserslautern-Landau, Germany |
Session Date: 23 May 2023
Session Time: 13:30-14:00 and 15:15-15:45
| Poster Number | Title | Presenter |
| PP-100 | Estimating the Potential Benefits of a Combined Covid-19/influenza Rapid Test Vs. Usual Diagnostic Practice in Patients with Influenza-like-illness | Julia Lowin, Vista Healthcare Pte Ltd, USA |
| PP-101 | The Application of Deep Inspiration Breath Hold in Left-sided Breast Radiotherapy: a Balance Between Side Effects and Costs | Sara Lise Busschaert, Vrije Universiteit Brussel, Belgium |
| PP-102 | Impact of Varying the Time Horizon On Cost-effectiveness Outcomes: Hemophilia As an Exemplary Disease | Nancy S. Bolous, St. Jude Children's Research Hospital, USA |
| PP-103 | Difficult Conversations in Kidney Care: a Resource Development Study to Support Discussions About Advance Care Planning and End-of-life | Hilary Louise Bekker, Leeds Teaching Hospitals NHS Trust, UK |
| PP-104 | Development and Evaluation of an Online Platform for Improved Perioperative Education in Patients Undergoing Ambulatory Carpal Tunnel Syndrome Release | Mariella Seel, Johannes Kepler University Linz, Austria |
| PP-105 | Structured Web-based Education Versus Self-directed Online Information Seeking in Patients Undergoing Ambulatory Carpal Tunnel Decompression Surgery | Mariella Seel, Johannes Kepler University Linz, Austria |
| PP-106 | Assessing Stakeholder Participation and Engagement in the Development of a Digital Platform for Health Promotion and Prevention in Settings | Mariella Seel, Univation Institut für Evaluation Dr. Beywl & Associates GmbH, Cologne, Germany, Germany |
| PP-107 | Developing a Core Outcome Set As Part of the Dutch Outcome-based Healthcare Program: an Example of Obesity Treatment | Esmee Van Der Willik, Dutch Healthcare Institute, Netherlands |
| PP-108 | Decision Aids to Support the German Second Opinion Directive On Surgical Treatments | Dennis Fechtelpeter, Institute for Quality and Efficiency in Health Care (IQWiG), Germany |
| PP-109 | Why Is It Difficult to Eliminate Hepatitis-c in Rural Pakistan? An Analysis of the Demographic Variables | Syed Uzair Mahmood, SHINE Humanity, Pakistan |
| PP-110 | Infrastructural Prerequisites for Mdm in the Practices of Office-based Haematologists/oncologists – the Accompanying Evaluation of the Neowis Project | Josephine Heinz, WINHO – Scientific Institute of Office-Based Haematologists and Oncologists, Germany |
| PP-111 | The Facilitators and Barriers to Reducing Falls Among Community-dwelling Older Adults From Clinicians’ Perspective: A Systems Modelling Approach | Vanessa Jean Wen Koh, Duke-NUS Medical School, Singapore |
| PP-112 | Carers’ Health-related Quality of Life in Economic Appraisals for Mental Health, Behavioural and Neurodevelopmental Conditions in England and Wales | Evelyn Gomez Espinosa, AmerisourceBergen, UK |
| PP-113 | A Systematic Review On Cost-effectiveness Studies Evaluating Hpv Self-testing for Cervical Cancer Screening | Lára Rún Hallsson, UMIT TIROL, Austria |
| PP-114 | Shared Decision Making Based On Patient Reported Outcomes in the Dutch Outcome Based Healthcare Program | Martijn Oude Voshaar, University of Twente, Netherlands |
| PP-115 | Identification of Risk Factors for Obesity to Feed a Risk Culture Model in the Euregio Regions: A Review | Julia Santamaria, UMIT TIROL, Austria |
| PP-116 | Development of a Logical Model of a Digital Platform for Health Promotion and Prevention | Ludwig Grillich, University for Continuing Education Krems, Austria |
| PP-117 | A Cost-effectiveness Framework to Evaluate Shared Decision-making: Application to Statin Initiation Decisions | Ankur Pandya, Harvard T.H. Chan School of Public Health, USA |
| PP-118 | Evaluation of the Degree of Student Participation in the Research Activity | Amangali Akanov, National Research Center of Health Development, Kazakhstan |
| PP-119 | Patients’ Perspectives On Ethical Principles to Fairly Allocate Scarce Surgical Resources During the Covid-19 Pandemic: a Q-methodology Study | Anouk Van Alphen, Erasmus University Medical Center, Netherlands |
| PP-120 | Collaborative Design in Research: Patient-led Community Advisory Boards | Rob Camp, EUPATI Spain, Spain |
| PP-121 | Ordering Effects in Threshold Technique Elicitation With Multiple Risks Included | Marco Boeri, RTI Health Solutions, UK |
| PP-122 | Bayesian Modeling of Health State Preferences: Can Existing Preference Data Be Used to Generate Better Estimates? | Samer A Kharroubi, American University of Beirut, Lebanon |
| PP-123 | Impact of Performing Imputation At Different Level of Missingness in Trial-based Cost-effectiveness Analysis with Multi-item Questionnaires | Xiaoxiao Ling, University College London, UK |
| PP-124 | First Fieller Now Euler: A Parametric Approach to Estimate the Probability That a Health Intervention Is Cost-effective Based On Euler’s Formula | Ali Jalali, Weill Cornell Medical College, USA |
| PP-125 | Assessing Collider Stratification Bias in Published Observational Studies of Stroke Patients: A Systematic Methods Evaluation | Nadja Wülk, Charité – Universitätsmedizin Berlin, Germany |
| PP-126 | Prediction of Prolonged Hospitalization After Admission Through the Emergency Department Using Machine Learning Techniques | Addisu Jember Zeleke, University of Bologna, Italy |
| PP-127 | Integrating Personalized Survival and Risk Scores in Decision Making About Left Ventricular Assist Device Therapy: Clinician and Patient Perspectives | Jennifer S. Blumenthal Barby, Baylor College of Medicine, USA |
Organised By
Kenes Group, Office: Kenes M+
#SMDM23BERLIN
